Tech Company Financing Transactions
Verrica Pharmaceuticals Funding Round
Verrica Pharmaceuticals, operating out of West Chester, secured $50 million from private investors.
Transaction Overview
Company Name
Announced On
7/26/2023
Transaction Type
Debt
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The Company will be able to borrow an aggregate of an additional $75 million available in five tranches, which the Company believes will be sufficient to fund ongoing operations without requiring additional equity financing. The facility is a five-year term loan that matures in July 2028.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
44 West Gay St 400
West Chester, PA 19380
USA
West Chester, PA 19380
USA
Phone
Undisclosed
Website
Email Address
Overview
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there's a better way to safely and effectively bring real relief to patients, advancing accessible therapies to prescribers and payers, and providing peace of mind to parents and caregivers. Verrica is focused on innovation, changing the narrative around viral skin diseases, and making treatment a more efficient process for both physicians and patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ted White
Chief Financial Officer
Terry Kohler
Chief Medical Officer
Gary Goldenberg
Browse more venture capital transactions:
Prev: 7/26/2023: AsclepiX Therapeutics venture capital transaction
Next: 7/26/2023: SearchStax venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs